Cargando…
Structural differences in 3C-like protease (Mpro) from SARS-CoV and SARS-CoV-2: molecular insights revealed by Molecular Dynamics Simulations
Novel coronavirus SARS-CoV-2 has infected millions of people with thousands of mortalities globally. The main protease (Mpro) is vital in processing replicase polyproteins. Both the CoV’s Mpro shares 97% identity, with 12 mutations, but none are present in the active site. Although many therapeutics...
Autores principales: | Parmar, Meet, Thumar, Ritik, Patel, Bhumi, Athar, Mohd, Jha, Prakash C., Patel, Dhaval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686461/ https://www.ncbi.nlm.nih.gov/pubmed/36467259 http://dx.doi.org/10.1007/s11224-022-02089-6 |
Ejemplares similares
-
Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches
por: Parmar, Meet, et al.
Publicado: (2022) -
Fragment-based design of SARS-CoV-2 Mpro inhibitors
por: Teli, Divya M., et al.
Publicado: (2022) -
Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease
por: Papaj, Katarzyna, et al.
Publicado: (2022) -
Advances in the Development of SARS-CoV-2 Mpro Inhibitors
por: Agost-Beltrán, Laura, et al.
Publicado: (2022) -
Dietary polyphenols mitigate SARS-CoV-2 main protease (Mpro)–Molecular dynamics, molecular mechanics, and density functional theory investigations
por: Adelusi, Temitope Isaac, et al.
Publicado: (2022)